A deep learning platform to assess drug proarrhythmia risk-Reference-Cited by-同舟云学术

A deep learning platform to assess drug proarrhythmia risk

Published:2023-01 Issue:1 Volume:30 Page:86-95.e4
ISSN:1934-5909
Container-title:Cell Stem Cell
language:en
Short-container-title:Cell Stem Cell

Author:

Serrano Ricardo,Feyen Dries A.M.,Bruyneel Arne A.N.,Hnatiuk Anna P.,Vu Michelle M.,Amatya Prashila L.,Perea-Gil Isaac,Prado Maricela,Seeger Timon,Wu Joseph C.,Karakikes Ioannis,Mercola Mark^ORCID

Publisher

Elsevier BV

Subject

Cell Biology,Genetics,Molecular Medicine

Reference60 articles.

1. Developing solutions to detect and avoid cardiovascular toxicity in the clinic;Valentin;Toxicology Letters,2018

2. Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature;Onakpoya;BMC Med.,2016

3. An analysis of the attrition of drug candidates from four major pharmaceutical companies;Waring;Nat. Rev. Drug Discov.,2015

4. Cardiac dysrhythmias associated with the intravenous administration of ondansetron and metoclopramide;Baguley;Anesth. Analg.,1997

5. Drug-induced proarrhythmia: risk factors and electrophysiological mechanisms;Frommeyer;Nat. Rev. Cardiol.,2016

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical trials in-a-dish for cardiovascular medicine;European Heart Journal;2024-09-13

2. An intelligent biosensing platform using phase space reconstruction‐assisted convolutional neural network for drug‐induced cardiotoxicity assessment;VIEW;2024-06-20

3. Using induced pluripotent stem cells for drug discovery in arrhythmias;Expert Opinion on Drug Discovery;2024-06-02

4. Design optimization of geometrically confined cardiac organoids enabled by machine learning techniques;Cell Reports Methods;2024-06

5. Tackling the challenges of new approach methods for predicting drug effects from model systems;Nature Reviews Drug Discovery;2024-05-15